Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume

OBJECTIVE: The treatment effects of vibegron have not previously been evaluated in a prospective, non-interventional observational study of elderly Japanese patients, particularly those ≥80 years old. In addition, no reports have referred to residual urine volume in switching cases. We therefore gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuno, Takahira, Tamura, Kenji, Shimizu, Nobutaka, Fukuhara, Hideo, Fukata, Satoshi, Ashida, Shingo, Karashima, Takashi, Satake, Hirofumi, Sawada, Kohji, Yamasaki, Ichiro, Komatsu, Fumito, Kuroiwa, Hajime, Saito, Motoaki, Inoue, Keiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216872/
https://www.ncbi.nlm.nih.gov/pubmed/37251707
http://dx.doi.org/10.2147/RRU.S411841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216872/
https://www.ncbi.nlm.nih.gov/pubmed/37251707
http://dx.doi.org/10.2147/RRU.S411841

Ejemplares similares